These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 22429105)

  • 1. Prolonged-release formulation of melatonin (Circadin) for the treatment of insomnia.
    Lemoine P; Zisapel N
    Expert Opin Pharmacother; 2012 Apr; 13(6):895-905. PubMed ID: 22429105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Melatonin: Physiological and pharmacological aspects related to sleep: The interest of a prolonged-release formulation (Circadin
    Quera-Salva MA; Claustrat B
    Encephale; 2018 Dec; 44(6):548-557. PubMed ID: 30107892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Controlled release melatonin (Circadin) in the treatment of insomnia in older patients: efficacy and safety in patients with history of use and non-use of hypnotic drugs].
    Zisapel N
    Harefuah; 2009 May; 148(5):337-41, 348. PubMed ID: 19630367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of prolonged release melatonin in insomnia patients aged 55-80 years: quality of sleep and next-day alertness outcomes.
    Wade AG; Ford I; Crawford G; McMahon AD; Nir T; Laudon M; Zisapel N
    Curr Med Res Opin; 2007 Oct; 23(10):2597-605. PubMed ID: 17875243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial on age and endogenous melatonin as predictors of efficacy and safety.
    Wade AG; Ford I; Crawford G; McConnachie A; Nir T; Laudon M; Zisapel N
    BMC Med; 2010 Aug; 8():51. PubMed ID: 20712869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged-release melatonin improves sleep quality and morning alertness in insomnia patients aged 55 years and older and has no withdrawal effects.
    Lemoine P; Nir T; Laudon M; Zisapel N
    J Sleep Res; 2007 Dec; 16(4):372-80. PubMed ID: 18036082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged release melatonin in the treatment of primary insomnia: evaluation of the age cut-off for short- and long-term response.
    Wade AG; Crawford G; Ford I; McConnachie A; Nir T; Laudon M; Zisapel N
    Curr Med Res Opin; 2011 Jan; 27(1):87-98. PubMed ID: 21091391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melatonin prolonged release: in the treatment of insomnia in patients aged ≥55 years.
    Lyseng-Williamson KA
    Drugs Aging; 2012 Nov; 29(11):911-23. PubMed ID: 23044640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lasting treatment effects in a postmarketing surveillance study of prolonged-release melatonin.
    Hajak G; Lemme K; Zisapel N
    Int Clin Psychopharmacol; 2015 Jan; 30(1):36-42. PubMed ID: 25054634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melatonin for primary insomnia?
    Drug Ther Bull; 2009 Jul; 47(7):74-7. PubMed ID: 19567841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged-release melatonin for the treatment of insomnia in patients over 55 years.
    Wade A; Downie S
    Expert Opin Investig Drugs; 2008 Oct; 17(10):1567-72. PubMed ID: 18808316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melatonin in medically ill patients with insomnia: a double-blind, placebo-controlled study.
    Andrade C; Srihari BS; Reddy KP; Chandramma L
    J Clin Psychiatry; 2001 Jan; 62(1):41-5. PubMed ID: 11235927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melatonin in elderly patients with insomnia. A systematic review.
    Olde Rikkert MG; Rigaud AS
    Z Gerontol Geriatr; 2001 Dec; 34(6):491-7. PubMed ID: 11828891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and Safety of Pediatric Prolonged-Release Melatonin for Insomnia in Children With Autism Spectrum Disorder.
    Gringras P; Nir T; Breddy J; Frydman-Marom A; Findling RL
    J Am Acad Child Adolesc Psychiatry; 2017 Nov; 56(11):948-957.e4. PubMed ID: 29096777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drugs for insomnia.
    Zisapel N
    Expert Opin Emerg Drugs; 2012 Sep; 17(3):299-317. PubMed ID: 22681198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-Term Efficacy and Safety of Pediatric Prolonged-Release Melatonin for Insomnia in Children with Autism Spectrum Disorder.
    Maras A; Schroder CM; Malow BA; Findling RL; Breddy J; Nir T; Shahmoon S; Zisapel N; Gringras P
    J Child Adolesc Psychopharmacol; 2018 Dec; 28(10):699-710. PubMed ID: 30132686
    [No Abstract]   [Full Text] [Related]  

  • 17. [Melatonin--a natural hypnotic?].
    Saletu B
    Wien Klin Wochenschr; 1997 Oct; 109(18):714-21. PubMed ID: 9441514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement of sleep quality in elderly people by controlled-release melatonin.
    Garfinkel D; Laudon M; Nof D; Zisapel N
    Lancet; 1995 Aug; 346(8974):541-4. PubMed ID: 7658780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sleep onset insomnia during childhood or poor fit between biology and culture: comment on van der Heijden et al. 'Prediction of melatonin efficacy by pre-treatment dim light melatonin onset in children with idiopathic chronic sleep onset insomnia'.
    Jenni OG
    J Sleep Res; 2005 Jun; 14(2):195-7; discussion 197-9. PubMed ID: 15910517
    [No Abstract]   [Full Text] [Related]  

  • 20. Case series of perimenopausal women with insomnia treated with mirtazapine followed by prolonged-release melatonin add-on and monotherapy.
    Dolev Z
    Arch Womens Ment Health; 2011 Jun; 14(3):269-73. PubMed ID: 21311927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.